All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-WFY0134 | Anti-EIF2AK2 (1441CT628-33-40) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 1441CT628-33-40 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0135 | Anti-EIF2AK2 (6H3A10) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 6H3A10 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0136 | Anti-EIF2AK2 (YE350) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | YE350 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0137 | Anti-EIF2AK2 (CBFYE-0180) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-0180 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0138 | Anti-EIF2AK2 (CBFYE-0644) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-0644 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3387 | Anti-EIF2AK2 (1441CT628-33-40) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 1441CT628-33-40 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3388 | Anti-EIF2AK2 (6H3A10) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 6H3A10 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3389 | Anti-EIF2AK2 (YE350) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | YE350 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3390 | Anti-EIF2AK2 (CBFYE-0180) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-0180 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3391 | Anti-EIF2AK2 (CBFYE-0644) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-0644 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION